ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Drug Discovery

DNA-encoded library firm X-Chem is acquired

by Michael McCoy
June 13, 2020 | APPEARED IN VOLUME 98, ISSUE 23

 

X-Chem, a provider of DNA-encoded libraries for drug discovery, has been bought by the European investment firm GHO Capital Partners for an undisclosed sum from two other investment firms. Based in Waltham, Massachusetts, X-Chem provides libraries containing over 200 billion small molecules. It counts Bayer, Pfizer, and Roche among its partners. Founder and current senior vice president of chemistry Matt Clark has become CEO.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment